MedPath

Depression in Pregnant women due to COVID-19 pandemic in India

Not Applicable
Completed
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/05/033545
Lead Sponsor
JSS college of Pharmacy Ooty
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Maternal age of 18 years or greater at the time of consent.

Gestational week: 32 to 40 weeks (Third trimester)

The ability to provide written informed consent.

Exclusion Criteria

Pregnant women with the gestational week under six (Early first trimester)

Pregnant women with chronic disease like chronic hypertension, kidney and liver disease, pre-pregnancy diabetes mellitus

Patient with reported depression in the past

History of use of anti-depressants and other drugs which cause depression.

History of high-risk pregnancy including abruption placenta, placenta previa, gestational diabetes, coagulation disorders, thrombocytopenia or history of drug abuse.

History of autoimmune diseases

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether COVID-19 pandemic is a possible risk factor for the development of depression among the pregnant and non-pregnant women.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Whether the COVID-19 pandemic has an impact on the maternal outcomes at delivery and neonatal outcomes at birthTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath